Cardiovascular risk and dyslipidemia;Risque cardio-vasculaire et dyslipidemies

Annales d'Endocrinologie

Volumn 59, Issue 4, 1998, Pages 335-343

  Verges B ^a  

^a HÔPITAL DU BOCAGE   (France)

Author keywords

Cardiovascular risk; Hyperlipidemia; Treatment

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DYSLIPIDEMIA; HUMAN; LIPOPROTEIN BLOOD LEVEL; MORBIDITY; MORTALITY; PATIENT EDUCATION; ARTERIOSCLEROSIS; BLOOD; HYPERLIPIDEMIA; INTERVENTION STUDY; REVIEW; RISK FACTOR;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; INTERVENTION STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 0032423151     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (12)

1. ALLEN JK, BLUMENTHAL RS, RAQUENO JV, HOCH J, MITCHELL S, DIETZ D. Risk factors in the offspring of women with premature coronary heart disease. Circulation 1996 ; 94 (Suppl) : 1-418.
2. AUSTIN MA. Plasma triglyceride and coronary heart disease. Arterioscl Thrombosis 1991 ; 11 : 2-14.
3. AUSTIN MA, BRESLOW JL, HENNEKENS CH, BURING JE, WILLET WL, KRAUSS RM. Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988 ; 260 : 1917-21.
4. AUSTIN MA, KINO MC, VRANIZAN KM, KRAUSS RM. Atherogenic lipoprotein phenotype : a proposed genetic marker for coronary heart disease risk. Circulation 1990 ; 82 : 495-506.
5. BERLINER JA, HEINECKE JW. The role of oxidized lipoproteins in atherogenesis. Free Rad Biol Med 1996 ; 207 : 707-727.
6. BLAKENHOM DM, NESSIM SA, JOHNSON RL et al. Beneficial effects of combined colestipol niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987 ; 257 : 23233-40.
7. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993 ; 87 : 1781-91.
8. BUCHWALD H, VARCO RC, MATT JP et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med 1990 ; 323 : 946-55.
9. BURKE AP, FARB A, MALCOM G, LIANY Y, SMIALEK S, VIRMANI R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997 ; 336 : 1276-82.
10. BURT A, THORNLEY P, ILLINGWATH et al. Stopping smoking after myocardial infarction. Lancet 1974 ; 1 : 304-6.
11. BYINGTON RP, JUKEMA JW, SALONEN JT et al. Reduction in cardio-vascular events during pravastatin therapy. Pooled analysis of clinical events of the pravastatin atherosclerosis intervention program. Circulation 1995 ; 92 : 2419-25.
12. CARLSON LA, ROSENHAMER H. Reduction of mortality in the Stockholm ischaemic heart disease study by combined treatment with clofibrate and nicomic acid. Acta Med Scand 1988 ; 223 : 405-18.